John M Rudey

This inventor holds 20 USPTO granted patents and 4 published patent applications. Top assignees: Epizon Pharma, Inc., Epizon, Inc., Epizon Phama, Inc.. Active years: 2020-2026.

USPTO Granted Patents = 20 (Patent Applications = 4)

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 62(Granted Patents)

Company Filing History:

Years Active: 2020-2026

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12514871 - Pegylated menaquinol compositions and methods of treatment (2026-01-06),

2. 12453700 - Nano-particles of menaquinone-9 and methods of treatment (2025-10-28),

3. 12433854 - Methods and compositions for preventing or treating calciphylaxis (2025-10-07),

4. 12383514 - Nano-particles of menaquinone and methods of treatment (2025-08-12),

5. 12377060 - Methods and compositions for preventing or treating tissue calcification (2025-08-05),

6. 12103914 - Compositions of biologically active menaquinol derivatives and methods of treatment (2024-10-01),

7. 11793773 - Methods and compositions for preventing or treating calciphylaxis (2023-10-24),

8. 11723882 - Methods and compositions for preventing or treating tissue calcification (2023-08-15),

9. 11603345 - Menaquinol compositions and methods of treatment (2023-03-14),

10. 11332427 - Menaquinol compositions and methods of treatment (2022-05-17),

11. 11065212 - Methods and compositions for preventing or treating calciphylaxis (2021-07-20),

12. 11033515 - Methods and compositions for preventing or treating tissue calcification (2021-06-15),

13. 10987320 - Methods and compositions for preventing or treating calciphylaxis (2021-04-27),

14. 10940123 - Methods and compositions for preventing or treating calciphylaxis (2021-03-09),

15. 10925838 - Methods and compositions for preventing or treating calciphylaxis (2021-02-23),

Title: John M Rudey: Innovator in Medical Treatments

Introduction

John M Rudey is a prominent inventor based in New York, NY, known for his significant contributions to medical treatments through his innovative patents. With a total of 19 patents to his name, Rudey has made strides in the field of healthcare, particularly in the treatment of conditions related to vitamin K2.

Latest Patents

Among his latest patents, Rudey has developed nanoparticles of menaquinone-9 and methods of treatment. This application discloses compositions comprising nanoparticles of vitamin K2 and their methods of use. Additionally, he has created methods and compositions for preventing or treating calciphylaxis. This invention provides methods for preventing or treating calciphylaxis in subjects with conditions such as diabetes, chronic kidney disease, end-stage renal failure, and COPD. It particularly focuses on the use of menaquinone-7 (MK-7) and/or menaquinol-7 (MKH2-7) for these treatments.

Career Highlights

Rudey has worked with notable companies in the pharmaceutical industry, including Epizon Pharma, Inc. and Epizon, Inc. His work in these organizations has allowed him to further develop his innovative ideas and contribute to advancements in medical treatments.

Collaborations

Throughout his career, Rudey has collaborated with esteemed colleagues such as James A Tumlin and Paul L Darke. These partnerships have played a crucial role in the development and success of his inventions.

Conclusion

John M Rudey's contributions to the field of medical treatments through his innovative patents highlight his dedication to improving healthcare. His work continues to influence the industry and offers promising solutions for various medical conditions.